NASDAQ: STLNStarling Oncology Inc Stock Ownership - Who owns Starling Oncology?
Insider buying vs selling
Have Starling Oncology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jorey Chernett | 10% Owner | 2026-11-09 | 48,294 | $3.65 | $176.27kBuy |
| Jorey Chernett | 10% Owner | 2026-11-06 | 2,851,061 | $3.99 | $11.38MSell |
| Brad Hively | Director | 2026-08-21 | 298,853 | $6.51 | $1.95MSell |
| Jorey Chernett | 10% Owner | 2026-08-14 | 12,000 | $6.54 | $78.48kBuy |
| Jorey Chernett | 10% Owner | 2026-07-21 | 18,000 | $5.27 | $94.86kBuy |
| Yale Podnos | Chief | 2026-07-14 | 17,974 | $1.87 | $33.61kBuy |
| Yale Podnos | Chief | 2026-07-14 | 17,974 | $6.43 | $115.55kSell |
| Yale Podnos | Chief | 2026-07-14 | 5,478 | $2.00 | $10.96kBuy |
| Yale Podnos | Chief | 2026-07-14 | 5,478 | $6.35 | $34.79kSell |
| Jorey Chernett | 10% Owner | 2026-07-10 | 15,000 | $5.85 | $87.75kBuy |
STLN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when STLN insiders and whales buy or sell their stock.
STLN Shareholders
What type of owners hold Starling Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ravi Yang Sarin | 12.16% | 12,404,740 | $49.62M | Insider |
| Jorey Chernett | 7.70% | 7,858,091 | $31.43M | Insider |
| Richard A. Barasch | 6.99% | 7,126,571 | $28.51M | Insider |
| M33 Growth I LP | 5.34% | 5,444,207 | $21.78M | Insider |
| James E. Flynn | 3.23% | 3,296,107 | $13.18M | Insider |
| Daniel Virnich | 2.29% | 2,337,166 | $9.35M | Insider |
| Mark L. Pacala | 0.50% | 511,852 | $2.05M | Insider |
| Mihir 1. Shah | 0.47% | 474,931 | $1.90M | Insider |
| Robert Ross Carter | 0.41% | 414,801 | $1.66M | Insider |
| Brad Hively | 0.40% | 411,976 | $1.65M | Insider |
STLN vs Medical Care Facility Stocks
Starling Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.